Followers | 201 |
Posts | 12072 |
Boards Moderated | 6 |
Alias Born | 06/20/2022 |
Monday, November 18, 2024 1:42:23 PM
Recent HCWB News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2024 09:42:31 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 11/20/2024 05:54:40 PM
- HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules • GlobeNewswire Inc. • 11/19/2024 02:27:48 AM
- HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate • GlobeNewswire Inc. • 11/18/2024 12:00:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2024 12:00:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 10:14:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 10:13:01 PM
- HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 11/14/2024 09:40:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 09:25:48 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/23/2024 08:35:07 PM
- HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction • GlobeNewswire Inc. • 08/23/2024 08:30:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:45:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:40:08 PM
- HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 08/14/2024 08:35:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:35:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 11:00:11 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 08:57:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:33:01 PM
- Form ARS/A - Annual Report to Security Holders: [Amend] • Edgar (US Regulatory) • 05/20/2024 08:36:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:21:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:45:13 PM
- HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 05/15/2024 08:39:10 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/15/2024 08:35:40 PM
- HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights • GlobeNewswire Inc. • 04/01/2024 08:10:32 PM
ILUS Agrees to Swap Majority Stake in Quality Industrial Corp. for Future Majority Stake in Fusion Fuel Green (NASDAQ: HTOO) • ILUS • Nov 20, 2024 9:07 AM
Avant Technologies and Ainnova Advancing Proprietary Retinal Camera to Market with Vision AI Software • AVAI • Nov 20, 2024 8:00 AM
Geo-Political Tensions and Trump's Increasing Military Budgets Could Boost Demand for Actelis' Cyber Hardened Networking Tech ($ASNS) • ASNS • Nov 19, 2024 10:24 AM
Key Metals Surge, Unlocking New Opportunities for Savvy Mining Investors • GDXJ • Nov 19, 2024 8:45 AM
Greenlane Signs New U.S. Distribution Agreement with Veriteque USA, Manufacturer of the SwabTek™ and Verifique™ Brand of Field Test Kits • GNLN • Nov 19, 2024 8:34 AM
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary • CBDL • Nov 19, 2024 8:00 AM